Article
Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing.
PloS one - 1 Jan 2017
Hill Victoria K, Kim Jung-Sik, James C David, Waldman Todd
Abstract excerpt
PTEN is among the most commonly mutated tumor suppressor genes in human cancer. However, studying the role of PTEN in the pathogenesis of cancer has been limited, in part, by the paucity of human cell-based isogenic systems that faithfully model PTEN loss. In an effort to remedy this problem, gene editing was used to correct an endogenous mutant allele of PTEN in two human glioblastoma multiforme (GBM) cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
